Back to NEUP

Lynx1 Capital Management LP → NEUP

Lynx1 Capital Management LP NEUP Position History

Neuphoria Therapeutics Inc. • Healthcare

Quarters held
5
Latest value
$3.1M
Q3 2026
Peak value
$3.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$3.4M
Q1 2026$3.6M
Q2 2026$3.8M
Q2 2026$3.8M
Q3 2026$3.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$3.1M875.3K——
Q2 2026$3.8M875.3K——
Q2 2026$3.8M875.3K——
Q1 2026$3.6M875.3K——
Q4 2025$3.4M875.2K——

Other funds holding NEUP

Other Lynx1 Capital Management LP positions

GHRS

GH RESEARCH PLC

$356.5M
GHRS

GH RESEARCH PLC

$311.4M
STOK

STOKE THERAPEUTICS INC

$171.5M
CGEM

CULLINAN THERAPEUTICS INC

$163.2M
CGEM

CULLINAN THERAPEUTICS INC

$163.2M
STOK

STOKE THERAPEUTICS INC

$155.1M
GHRS

GH RESEARCH PLC

$151.3M
CGEM

CULLINAN THERAPEUTICS INC

$137.6M